-Deccan Herald Rights activists led by Aruna Roy on Monday demanded that the proposed Whistleblowers Protection Bill and the Grievance Redressal Bill be made more stringent. At a public debate involving intellectuals and MPs, the activists suggested that both the Bills, pending in Parliament, should be amended. The Whistleblowers Bill has been passed by Lok Sabha and is awaiting Rajya Sabha nod, while the Grievance Redressal Bill is still in Lok Sabha. National Campaign...
More »SEARCH RESULT
Total Matching Records found : 505
CAG criticizes atomic energy regulator over policy gaps-Jacob P Koshy
-Live Mint The Comptroller and Auditor General (CAG) has criticized India’s atomic energy regulator for not being truly independent, not having a radiation safety policy and being lax in monitoring the proliferation of unregistered medical X-ray facilities in the country. This is the first time ever that the performance of the 29-year-old Atomic Energy Regulatory Board (AERB) has been reviewed by the government’s auditor. The move follows criticism of the safety of...
More »1144 Deaths During Clinical Drug Trials in 2 Years: Govt
-PTI Clinical drug trials in India led to the death of 1144 people in 2010 and 2011, the government today said. The number of people dying during such trials also include 1106 people whose death could be attributed to diseases like cancer, terminal illness or various unrelated causes which is also known as Serious Adverse Event (SAE) of death, Health and Family Welfare Minister Ghulam Nabi Azad told the Rajya Sabha. "The number...
More »Street vendors hail new Bill
-The Hindu A day after the Union Cabinet approved the Street Vendors (Protection of Livelihood & Regulation of Street Vending) Bill, 2012, the National Association of Street Vendors of India organised a meeting at Jantar Mantar on Saturday and hailed the decision with the hope that Parliament would now pass the Bill in its current session. Association national coordinator Arbind Singh said, “The struggle of street vendors has yielded result. We have...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
